RECOMMENDATIONS

Document Overview

Design and created by Guideline Central in participation with the Canadian Coalition for Seniors’ Mental Health.

Benzodiazepine Receptor Agonist Use Disorder Among Older Adults

Canadian Coalition for Seniors’ Mental Health

Publication Date: Jan 1, 2020

Page Last Updated: Feb 12, 2026

Society of American Gastrointestinal and Endoscopic Surgeons GRADE Table

Document Overview

Document Title: Benzodiazepine Receptor Agonist Use Disorder Among Older Adults

Authoring Society: Canadian Coalition for Seniors’ Mental Health

Document Publication Date: Jan 1, 2020

Page Last Reviewed/Updated: Feb 12, 2026

Document Type: Guideline

Country of Publication: Canada

Full Text Freely Available: Yes

Full Text Guideline: ccsmh.ca/wp-content/uploads/2020/01/Benzodiazepine_Receptor_Agonist_Use_Disorder_ENG_Jan-24.pdf

Source Citation: Conn DK, Hogan DB, Amdam L, Cassidy KL, Cordell P, Frank C, Gardner D, Goldhar M, Ho JM, Kitamura C, Vasil N. Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults Title. Can Geriatr J. 2020 Mar 30;23(1):116-122. doi: 10.5770/cgj.23.419. PMID: 32226570; PMCID: PMC7067147.

Supplemental Implementation Resources

Document Scope, Criteria, and Use Cases

Scope: Assessment and Screening, Counseling, Diagnosis, Management, Prevention, Treatment

Diseases/Conditions (MeSH)

D019966 - Substance-Related Disorders

D001569 - Benzodiazepines

Keywords: BZRA, Benzodiazepine Receptor, Use Disorder

Health Care Settings: Ambulatory, Correctional Facility, Hospital

Intended Users: Addiction Treatment Specialist, Nurse, Nurse Practitioner, Physician, Physician Assistant, Psychologist

Recommendation Development Processes & Methodology

Supplemental Methodology Resource: Methodology Supplement

Number of Source Documents: 115

Includes peer/external review process?: Yes

Includes public comment process?: No

Methodologist involvement?: Yes

Patient involvement?: No

Includes multi-disciplinary group?: Yes

Includes systematic review?: Yes

Grades quality of strength of evidence?: Yes

Grades quality of strength of recommendation?: Yes

Discloses funding source?: Yes

Discloses conflicts of interest?: Yes

Includes benefits/harms analysis with recommendations?: No